Biotoxtech Co., Ltd. (KOSDAQ:086040)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,380.00
+45.00 (1.93%)
At close: Aug 24, 2026

Biotoxtech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
15,52018,63211,37027,47912,70018,592
Short-Term Investments
10,0009,50019,00013,55917,0599,559
Trading Asset Securities
--2,014-1,012-
Cash & Short-Term Investments
25,52028,13232,38441,03830,77128,151
Cash Growth
-13.03%-13.13%-21.09%33.37%9.31%32.97%
Accounts Receivable
8,1028,7007,8635,3557,3525,813
Other Receivables
206376.02462.71445.37158.21,055
Receivables
11,03511,8039,9188,39210,2618,631
Inventory
7,5977,21814,78611,9154,454674.04
Prepaid Expenses
382.15187.05423.32113.14257.66202.19
Other Current Assets
1,5851,2751,4063,2333,38788.11
Total Current Assets
46,11948,61558,91864,69249,13037,746
Property, Plant & Equipment
55,73655,07156,51658,18158,06625,409
Long-Term Investments
19,02718,90210,32010,68910,13018,373
Other Intangible Assets
1,1881,2761,6651,5961,4831,479
Long-Term Deferred Tax Assets
944.12732.721,8525,3441,072565.72
Long-Term Deferred Charges
-----58.46
Other Long-Term Assets
2,8502,8152,0931,865819.422,110
Total Assets
130,059131,607136,191147,036125,70090,741

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
728.95687.72673.72541.98783.54815.54
Accrued Expenses
578.95689.13183.2280.55628.1
Short-Term Debt
46,89446,03742,81841,22927,85323,843
Current Portion of Long-Term Debt
5,0005,0003,750-1,0001,000
Current Portion of Leases
188.88135.06165.46171.03150.43199.46
Current Income Taxes Payable
----250.2948.79
Current Unearned Revenue
4.5911.46----
Other Current Liabilities
34,04932,93234,61933,09629,43519,841
Total Current Liabilities
87,44485,49282,21075,11959,52845,777
Long-Term Debt
10,00011,25016,25020,00020,0001,909
Long-Term Leases
109.6977.9165.74191.59136.8197.13
Pension & Post-Retirement Benefits
3,0362,6713,0413,3201,5081,070
Other Long-Term Liabilities
222.49184.5299.68171.68161.138.12
Total Liabilities
100,81299,676101,66698,80181,33448,892

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7,9797,9797,9797,9797,3347,334
Additional Paid-In Capital
32,51632,51632,51634,12521,59821,058
Retained Earnings
-710.731,16158.566,74012,1629,354
Treasury Stock
-2,161-2,161-1,163-165.68-165.68-165.68
Comprehensive Income & Other
674.66662.67691.383,0323,3073,563
Total Common Equity
38,29840,15740,08251,71044,23541,144
Minority Interest
-9,051-8,226-5,557-3,475131.97705.69
Shareholders' Equity
29,24731,93134,52548,23544,36741,849
Total Liabilities & Equity
130,059131,607136,191147,036125,70090,741

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
62,19262,50063,04961,59149,14027,049
Net Cash (Debt)
-36,673-34,367-30,665-20,553-18,3691,102
Net Cash Growth
------71.82%
Net Cash Per Share
-2359.19-2199.82-1932.30-1332.10-1255.0371.58
Filing Date Shares Outstanding
15.4115.4115.7215.9314.6414.64
Total Common Shares Outstanding
15.4115.4115.7215.9314.6414.64
Working Capital
-41,324-36,877-23,292-10,426-10,398-8,031
Book Value Per Share
2485.922606.612549.633246.603022.262811.05
Tangible Book Value
37,11138,88238,41750,11542,75239,665
Tangible Book Value Per Share
2408.842523.812443.713146.422920.962710.03
Land
6,6686,6686,6686,6686,6686,650
Buildings
51,83451,81751,80851,45851,21322,710
Machinery
15,36114,19513,69413,20310,9134,666
Construction In Progress
141.881.44651.78131.61,654